Pages that link to "Q34960856"
Jump to navigation
Jump to search
The following pages link to Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence (Q34960856):
Displayed 50 items.
- Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells (Q24548940) (← links)
- Redefining the viral reservoirs that prevent HIV-1 eradication (Q26827255) (← links)
- Animal models in HIV cure research (Q26853069) (← links)
- New assays for monitoring residual HIV burden in effectively treated individuals (Q26863589) (← links)
- HIV-1 eradication strategies: design and assessment (Q26864933) (← links)
- The immunological synapse: the gateway to the HIV reservoir (Q27002959) (← links)
- Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model (Q27335485) (← links)
- Depletion of latent HIV-1 infection in vivo: a proof-of-concept study (Q28111910) (← links)
- Viral and latent reservoir persistence in HIV-1-infected patients on therapy (Q28469057) (← links)
- Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe (Q28474278) (← links)
- HIV promoter integration site primarily modulates transcriptional burst size rather than frequency (Q28475647) (← links)
- X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHI (Q28476667) (← links)
- Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy (Q28478666) (← links)
- An "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cells (Q28482134) (← links)
- Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells (Q33250088) (← links)
- Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART (Q33296883) (← links)
- Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART. (Q33313038) (← links)
- CpG methylation controls reactivation of HIV from latency (Q33495565) (← links)
- The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy (Q33507274) (← links)
- Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy (Q33510903) (← links)
- Measuring reversal of HIV-1 latency ex vivo using cells from infected individuals (Q33627182) (← links)
- Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS (Q33676630) (← links)
- Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. (Q33716348) (← links)
- Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. (Q33717839) (← links)
- In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. (Q33724206) (← links)
- A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients (Q33724247) (← links)
- Combinatorial latency reactivation for HIV-1 subtypes and variants (Q33877492) (← links)
- Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions (Q33883813) (← links)
- Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. (Q33900251) (← links)
- Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus (Q33908838) (← links)
- Rapid turnover of 2-LTR HIV-1 DNA during early stage of highly active antiretroviral therapy. (Q33936651) (← links)
- Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB (Q34482017) (← links)
- Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy (Q34588169) (← links)
- Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies (Q34607763) (← links)
- Highly precise measurement of HIV DNA by droplet digital PCR. (Q34661612) (← links)
- Pharmaceutical approaches to eradication of persistent HIV infection (Q34941973) (← links)
- Measuring turnover of SIV DNA in resting CD4+ T cells using pyrosequencing: implications for the timing of HIV eradication therapies (Q35141776) (← links)
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication (Q35158133) (← links)
- Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations (Q35521811) (← links)
- Generation of HIV latency in humanized BLT mice (Q35666126) (← links)
- Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific (Q35667591) (← links)
- HIV-1 dynamics in vivo: implications for therapy (Q35701633) (← links)
- Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. (Q35720063) (← links)
- Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity (Q35761152) (← links)
- Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs (Q35830264) (← links)
- Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection (Q36066494) (← links)
- Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes (Q36098975) (← links)
- Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure (Q36102538) (← links)
- Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation (Q36409885) (← links)
- Recent developments in the effort to cure HIV infection: going beyond N = 1. (Q36515170) (← links)